is categorised as a sexually transmitted disease/infection (STI) which is caused by herpes simplex virus. Genital herpes is diagnosed by painful blisters on and areas surrounding genitals of both men and women affecting mucus membrane present in the body. Genital herpes is mostly common amongst women when compared with men. Genital herpes is a chronic condition and currently no permanent cure has been discovered. However, medication is available to reduce triggered symptoms of the disease. Globally increasing awareness about STD is expected to remain key driving factor for genital herpes treatment market during the period of study.
This report identifies the
genital herpes treatment market
size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the potential growth opportunities in the coming years, while also reviewing the market drivers, restraints, growth indicators, challenges, market dynamics, competitive landscape and other key aspects with respect to genital herpes treatment market.
Globally North America dominates the market for genital herpes treatment in 2015 with highest market share due to strong network of healthcare setup and people having good awareness about sexually transmitted diseases/infections. North America was followed by Europe as the second largest regional market for genital herpes treatment. However, Asia-Pacific is expected to be the fastest growing regional segment during the period of study due to increasing awareness about genital herpes treatment and rapidly developing hospital network in the region.